President Trump signed a nationwide law into effect that might provide a pathway to treatment with experimental drugs and therapies. The devil is in the details. How long does the process take and how is payment calculated and arranged ? People contemplating foreign travel to get Lu-177 treatment should maybe contact Novartis, the LU-177 patent holder in the U.S. and sponsor of the phase 3 "Vision" trial NCT03511664 and see what they have to say.. One glitch I see is that only the big research hospitals have the expertise and facilities to administer radio-pharmaceutical compounds like Lu-177..
"Right-to-try laws are U.S. state laws and a federal law that were created with the intent of allowing terminally ill patients access to experimental therapies (drugs, biologics, devices) that have completed Phase I testing but have not been approved by the Food and Drug Administration (FDA)."